Bosutinib Recruiting Phase 2 Trials for Chronic / BCR-ABL Positive / Myelogenous / Leukemias Treatment

Indications	Status	Purpose	Phase
DBCOND0030707 (Chronic) DBCOND0059313 (BCR-ABL Positive) DBCOND0076228 (Myelogenous) DBCOND0035632 (Leukemias)	Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT02638467	Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy	Bosutinib (DB06616)